Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value
$324.24M
Total Bought
$157.82M
Total Sold
$120.22M
Net Transaction
+$37.60M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc0193,000+193,000014,2034.38%+14,203
Rocket Pharmaceuticals Inc(RCKT)0382,672+382,672011,4693.54%+11,469
Medtronic PLC(MDT)0135,000+135,000011,1213.43%+11,121
Sanofi SA(SNY)0220,000+220,000010,9413.37%+10,941
Celldex Therapeutics Inc(CLDX)0247,215+247,21509,8053.02%+9,805
Mersana Therapeutics Inc5,000,0006,420,136+1,420,1366,35014,8954.59%+8,545
Praxis Precision Medicines Inc(PRAX)0283,841+283,84106,3241.95%+6,324
MacroGenics Inc(MGNX)1,264,1581,258,641-5,5175,89112,1083.73%+6,217
Merus NV500,000645,581+145,58111,79017,7535.48%+5,963
Alpine Immune Sciences Inc0297,789+297,78905,6761.75%+5,676
Xenon Pharmaceuticals Inc(XENE)53,996163,168+109,1721,8457,5162.32%+5,671
Intuitive Surgical Inc015,808+15,80805,3331.64%+5,333
Penumbra Inc(PEN)020,000+20,00005,0311.55%+5,031
Scholar Rock Holding Corp(SRRK)9,711270,000+260,289695,0761.57%+5,007
Akero Therapeutics Inc31,336249,254+217,9181,5855,8201.79%+4,235
Oric Pharmaceuticals Inc(ORIC)1,123,3451,170,000+46,6556,79610,7643.32%+3,968
Poseida Therapeutics Inc3,567,9853,705,779+137,7948,49212,4513.84%+3,960
DexCom Inc(DXCM)031,000+31,00003,8471.19%+3,847
Solid Biosciences Inc0594,855+594,85503,6521.13%+3,652
Sarepta Therapeutics Inc(SRPT)9,19746,884+37,6871,1154,5211.39%+3,406
MoonLake Immunotherapeutics(MLTX)050,000+50,00003,0200.93%+3,020
Olema Pharmaceuticals Inc(OLMA)407,801573,830+166,0295,0368,0512.48%+3,014
Biohaven Ltd(BHVN)10,00070,695+60,6952603,0260.93%+2,766
Rhythm Pharmaceuticals Inc(RYTM)260,537174,248-86,2895,9738,0102.47%+2,037
argenx SE(ARGX)04,826+4,82601,8360.57%+1,836
Pmv Pharmaceuticals Inc(PMVP)0550,000+550,00001,7050.53%+1,705
Altimmune Inc(ALT)0150,000+150,00001,6880.52%+1,688
Compugen Ltd(CGEN)350,188940,000+589,8123261,8610.57%+1,536
Veracyte Inc(VCYT)239,571247,723+8,1525,3506,8152.10%+1,465
Pliant Therapeutics Inc(PLRX)250,409318,524+68,1154,3425,7681.78%+1,426
Tela Bio Inc(TELA)490,471795,080+304,6093,9245,2631.62%+1,340
Cerus Corp(CERS)1,203,8901,499,851+295,9611,9503,2401.00%+1,289
Kodiak Sciences Inc(KOD)1,114,4611,000,000-114,4612,0063,0400.94%+1,034
Insmed Inc(INSM)150,387155,504+5,1173,7974,8191.49%+1,022
Annexon Inc(ANNX)399,716417,429+17,7139431,8950.58%+952
Morphic Holding Inc590,829500,042-90,78713,53614,4414.45%+905
Caribou Biosciences Inc(CRBU)892,786900,818+8,0324,2685,1621.59%+894
89bio Inc60,247158,719+98,4729301,7730.55%+843
Immunovant Inc(IMVT)020,000+20,00008430.26%+843
Terns Pharmaceuticals Inc500,000516,999+16,9992,5153,3551.03%+840
Evogene Ltd3,100,0003,100,00001,8182,6040.80%+786
Urogen Pharma Ltd(URGN)508,883525,404+16,5217,1297,8812.43%+752
Apellis Pharmaceuticals Inc
COM
010,000+10,00005990.18%+599
Gossamer Bio Inc(GOSS)6,130,2686,130,26805,1055,5941.73%+489
Viridian Therapeutics Inc(VRDN)47,43850,438+3,0007281,0990.34%+371
Schrodinger Inc(SDGR)30,31131,117+8068571,1140.34%+257
Relmada Therapeutics Inc(RLMD)100,000100,00003004140.13%+114
Rocket Pharmaceuticals Inc Wts(RCKT)104,828104,828018510.02%+34
Intellia Therapeutics Inc(NTLA)53,01854,822+1,8041,6761,6720.52%-5
Aligos Therapeutics Inc631,887668,512+36,6254724440.14%-28
Clene Inc(CLNN)500,0000-500,0002480—-248
Eloxx Pharmaceuticals Inc54,0750-54,0752600—-260
Karyopharm Therapeutics Inc(KPTI)561,955561,95507534860.15%-267
Syndax Pharmaceuticals Inc(SNDX)20,0000-20,0002900—-290
Eliem Therapeutics Inc(CLYM)121,1100-121,1103190—-319
Rezolute Inc(RZLT)433,240157,085-276,1555721560.05%-416
Zura Bio Ltd(ZURA)404,040462,997+58,9572,6672,1620.67%-504
Point Biopharma Global Inc93,7000-93,7006250—-625
Cogent Biosciences Inc(COGT)651,372966,748+315,3766,3515,6841.75%-666
Voyager Therapeutics Inc(VYGR)103,9660-103,9668060—-806
KalVista Pharmaceuticals Inc228,934111,734-117,2002,2051,3690.42%-836
Trevi Therapeutics Inc(TRVI)927,415863,883-63,5322,0221,1580.36%-864
Sagimet Biosciences Inc(SGMT)100,0000-100,0008800—-880
BioMarin Pharmaceutical Inc(BMRN)10,0000-10,0008850—-885
Molecular Templates Inc354,608354,60802,2411,3230.41%-918
Mirum Pharmaceuticals Inc(MIRM)110,11480,811-29,3033,4802,3860.74%-1,094
Alkermes Plc(ALKS)41,4550-41,4551,1610—-1,161
Roivant Sciences Ltd(ROIV)100,0000-100,0001,1680—-1,168
Prothena Corporation PLC
SHS
26,6290-26,6291,2850—-1,285
Aerovate Therapeutics Inc100,0000-100,0001,3570—-1,357
Biogen Idec Inc(BIIB)28,06920,000-8,0697,2145,1751.60%-2,039
United Therapeutics Corp(UTHR)31,42416,360-15,0647,0983,5971.11%-3,500
CymaBay Therapeutics Inc590,000218,975-371,0258,7975,1721.60%-3,625
BioCryst Pharmaceuticals Inc(BCRX)791,671248,728-542,9435,6051,4900.46%-4,115
Gilead Sciences Inc(GILD)62,7890-62,7894,7050—-4,705
Vertex Pharmaceuticals Inc(VRTX)13,7650-13,7654,7870—-4,787
Humana Inc(HUM)10,0000-10,0004,8650—-4,865
Intra-Cellular Therapies Inc208,73080,000-128,73010,8735,7301.77%-5,143
Novo Nordisk A/S(NVO)60,0000-60,0005,4560—-5,456
Crinetics Pharmaceuticals Inc(CRNX)220,0000-220,0006,5430—-6,543
Praxis Precision Medicines Inc4,117,9200-4,117,9207,0420—-7,042
Soleno Therapeutics Inc370,00073,665-296,33510,9192,9650.91%-7,954
Krystal Biotech Inc(KRYS)71,5310-71,5318,2980—-8,298
Mirati Therapeutics Inc200,0000-200,0008,7120—-8,712
ImmunoGen Inc1,307,4350-1,307,43520,7490—-20,749
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q4 2023 | TickerTrail